News
Why Achillion Pharmaceuticals Crashed 22.2% Today
After Johnson & Johnson (NYSE: JNJ) announced it's ending its agreement to develop Achillion Pharmaceuticals' (NASDAQ: ACHN) hepatitis C drugs, Achillion Pharmaceuticals shares lost 22.2% of....
Why Equifax, Regeneron Pharmaceuticals, and AngloGold Ashanti Slumped Today
Monday was a good day for the stock market, with most investors breathing a big sigh of relief despite the devastation that Hurricane Irma caused in the Southeastern U.S. over the weekend. Irma....
Why Teva Pharmaceutical Industries, MercadoLibre, and XL Group Jumped Today
The stock market soared on Monday, with major benchmarks finishing higher by 1% or more following a weekend that featured somewhat less devastation than many had feared. Hurricane Irma spent most....
Why August Was a Bad Month for Oil Drillers
Shares of many oil exploration and production stocks dropped more than 14% in August, including Parsley Energy (NYSE: PE), down 14.3%; Sanchez Energy (NYSE: SN), down 14.6%; Concho....
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
Gilead Sciences' (NASDAQ: GILD) executives answered several questions about its pending acquisition of Kite Pharma (NASDAQ: KITE) last week at the Citi biotech conference. However, that discussion....
1 Bizarre Excerpt From Fortune's Interview With Apple CEO Tim Cook
On the eve of Apple's (NASDAQ: AAPL) highly anticipated iPhone event tomorrow, Fortune has just published an interview with CEO Tim Cook covering a wide range of topics. Executive editor Adam....
What Investors Might Have Missed in the Market Last Week
Last week had a lot of news. Aside from all eyes focusing on Hurrican Irma, concerns again grew about tensions with North Korea and investors grew pessimistic about an interest rate hike by year's....
Why Teva Pharmaceutical Industries Ltd. (ADR) Is Soaring
After announcing that it has officially filled its vacant CEO seat, Teva Pharmaceutical Industries (NYSE: TEVA), a pharma company primarily focused on generic drugs, jumped 18% as of 1:45 p.m. EDT....
Why Tesla, Inc. Stock Is Up on Monday
Shares of electric-car maker Tesla (NASDAQ: TSLA) moved higher on Monday, rising as much as 4.9%. The stock is up about 4.6% at the time of this writing.The stock's gain comes amid an overall rise....
Tesla Inc. Brings Its Superchargers to Urban Areas
Ahead of high-volume production of its recently launched Model 3, Tesla's (NASDAQ: TSLA) has been revamping its Supercharger program to meet the needs of a much larger vehicle fleet. From....
A Foolish Take: The Most Productive Fast-Food Chains in America
The American fast-food industry may seem vulnerable to healthier eating habits and lower grocery prices, but it's still growing at a steady pace. However, consumer tastes are changing, and....
Here's Why Idera Pharmaceuticals, Inc. Is Surging Today
Shares of Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biotech advancing novel therapies for skin-related diseases, are getting a bump after the company presented trial results at....
DOW DAX mit der Entladung
ie Situation hatten wir ja lange genug durchgekaut. Ein Ausbruch nach oben würde zu einer Entladung führen. Dies haben wir gesehen und der DAX explodiert nach oben. Auch die Situation vor den Wahlen
Better Buy: Realty Income Corporation vs. Simon Property Group
Realty Income Corporation (NYSE: O) is the largest real estate investment trust, or REIT, specializing in net-leased freestanding retail properties. Simon Property Group (NYSE: SPG) is not only....
Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August
Despite a stronger-than-expected second quarter earnings report, Allergan's (NYSE: AGN) two month long rally came to an abrupt halt in August with the stock losing 9.9% of its value, according to....
3 Stocks That Could Put Intel's Returns to Shame
Investors in Intel (NASDAQ: INTC) have enjoyed market-drubbing returns for decades, although at various times, the chipmaker's stock has stumbled from a combination of competitive pressures,....
Is TransCanada Corporation a Buy?
TransCanada (NYSE: TRP) has been a steady performer for investors over the years. Since 2000, for example, it has delivered 14% average annual returns for investors, thanks in part to delivering....
Why Biogen Stock Raced Higher In August
Biotech titan Biogen (NASDAQ: BIIB) saw its shares rise by 8.73% last month, according to data from S&P Global Market Intelligence. This healthy march northward was sparked by an encouraging....
Starbucks Puts Its High-End Strategy to the Test
Starbucks (NASDAQ: SBUX) wants to change the coffee scene in the United States once again.The chain, which introduced European-style coffee houses to the U.S., now has plans to create a whole new....
Could Skyworks Solutions, Inc. Be a Millionaire Maker Stock?
Skyworks Solutions (NASDAQ: SWKS) -- which produces power amplifiers, front-end modules, and RF chips for a wide variety of markets -- rallied more than 1,200% over the past decade. This means....
How Safe Is ExxonMobil's Dividend?
The energy sector has been under substantial pressure over the past couple of years, but integrated oil giant ExxonMobil (NYSE: XOM) has held up far better than many smaller players that focus....
4 Reasons to Buy Intuitive Surgical, Inc. Stock and Never Sell
Before starting, a confession is in order: Over the seven years that I've been a shareholder of Intuitive Surgical (NASDAQ: ISRG), there was a time that I actually sold some of the stock. My....
Why Baker Hughes, a GE Company, Dropped 5% in August
Shares of oil-services company Baker Hughes, a GE Company (NYSE: BHGE) fell 5% in August, the first full month since the company's official takeover by General Electric (NYSE: GE). While that....
My Credit Score Is 700. Now What?
A credit score of 700 is considered "good" by FICO, and although it's not in "very good" or "exceptional" territory, it should qualify you for the best terms on most loans. Here's how you can use....
5 Things GameStop Management Wants You to Know
GameStop (NYSE: GME) stock has been hammered in 2017, trading down roughly 25% year to date and 13% since the company's Aug. 24 second-quarter earnings release. The core issue facing the....